Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
MainStay Epoch US Equity Yield Investor EPLIX
- NAV / 1-Day Return 21.07 / +0.32 %
- Total Assets 1.0 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.330%
- Distribution Fee Level High
- Share Class Type Front Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.73%
- Turnover 19%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:04 PM GMT+0
Morningstar’s Analysis EPLIX
Will EPLIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 21.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
JPMorgan Chase & Co | 2.54 | 25.0 Mil | Financial Services |
Broadcom Inc | 2.46 | 24.2 Mil | Technology |
Eli Lilly and Co | 2.28 | 22.4 Mil | Healthcare |
Bank of America Corp | 2.22 | 21.8 Mil | Financial Services |
MetLife Inc | 2.14 | 21.1 Mil | Financial Services |
AbbVie Inc | 2.12 | 20.8 Mil | Healthcare |
Merck & Co Inc | 2.04 | 20.0 Mil | Healthcare |
Cummins Inc | 1.95 | 19.1 Mil | Industrials |
UnitedHealth Group Inc | 1.76 | 17.3 Mil | Healthcare |
Johnson & Johnson | 1.75 | 17.2 Mil | Healthcare |